Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Antioxidant, Cytotoxic Activity and Protein Target Inhibition of Ethyl Acetate Fraction Melinjo Seed (Gnetum gnemon L.) by In Vitro and In Silico Studies on HeLa Cervical Cancer Cells

HAYATI Journal of Biosciences · Vol. 30 No. 5 (2023) · hlm. 864–873

DOI
10.4308/hjb.30.5.864-873
ISSN
2086-4094, 1978-3019
Terbit
2023-06-19
Penerbit
Bogor Agricultural University, Indonesia
Bahasa
eng

Abstrak

Cervical cancer is one of the most common cancer suffered in women. Chemotherapy usage often causes physical and psychological side effects in patients. This study aims to determine the antioxidant and cytotoxic effects of the ethyl acetate fraction of melinjo seeds (Gnetum gnemon L.) on HeLa cervical cancer cells through in vitro and in silico assays. Melinjo seed was extracted by maceration using ethanol 70% and fractionated with ethyl acetate to obtain the Ethyl Acetate Fraction of Melinjo Seed (EAFMS). The identification of the active compounds group was done using Thin Layer Chromatography (TLC) method. In vitro studies were conducted on antioxidant tests using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method and cytotoxic activity test using 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) Assay. In silico test for molecular docking analyzed by Autodock Vina method. The TLC analysis of EAFMS showed the presence of the stilbenoid compounds group. The antioxidant activity of EAFMS is weak, with an IC50 value of 175.8 g/ml. Cytotoxic activity of EAFMS is categorized as toxic to HeLa cancer cells with an IC50 value of 21.69 g/ml, while EAFMS has a synergistic effect combined with doxorubicin as a standard drug with a combination index (CI) value of 0.24-0.80. A molecular docking test of gnetin C with VHR receptor found a strong and stable bond with a docking score of -8.3 kcal/mol. Thus, EAFMS has the potential to be used as a chemopreventive agent for cervical cancer and can be combined with doxorubicin.

Jaringan kolaborasi para penulis

21 penulis · 53 tautan kepenulisan bersama · 14 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Muhammadiyah University of Yogyakarta
  • Universitas Gadjah Mada
  • Sumatera Institute of Technology
  • Universitas Jember
  • Politeknik Kesehatan Bhakti Setya Indonesia
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Triana Arum KusumaningtyasMuhammadiyah University of Yogyakarta3
Ivana Kinanti KenyoriMuhammadiyah University of Yogyakarta3
Melisa JunianandaMuhammadiyah University of Yogyakarta2
Dhecella Winy Cintya NingrumMuhammadiyah University of Yogyakarta2
Melany Ayu OctaviaMuhammadiyah University of Yogyakarta2
Adi HermawansyahMuhammadiyah University of Yogyakarta1
Chaessy Yori AnggrainiMuhammadiyah University of Yogyakarta1
Aji WinantaMuhammadiyah University of Yogyakarta1
Linta Sabila HanikMuhammadiyah University of Yogyakarta1
Endah PuspitasariUniversitas Jember1
Dyaningtyas Dewi Pamungkas PutriUniversitas Gadjah Mada1
Sarmoko SarmokoSumatera Institute of Technology1
Nur IsmiyatiPoliteknik Kesehatan Bhakti Setya Indonesia1
Aditya FitriasariUniversitas Gadjah Mada1
Vidia NoviyantiMuhammadiyah University of Yogyakarta1
Alfiah AmaliyahMuhammadiyah University of Yogyakarta1
Sri TasminatunMuhammadiyah University of Yogyakarta1
Annisa KrisridwanyMuhammadiyah University of Yogyakarta1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://journal.ipb.ac.id/index.php/hayati/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Antioxidant, Cytotoxic Activity and Protein Target Inhibition of Ethyl Acetate Fraction Melinjo Seed (Gnetum gnemon L.) by In Vitro and In Silico Studies on HeLa Cervical Cancer Cells</dc:title>
	<dc:creator xml:lang="en">Savitri, Rawi Ingra</dc:creator>
	<dc:creator xml:lang="en">Arifin, Nuha Haifa</dc:creator>
	<dc:creator xml:lang="en">Febriansah, Rifki</dc:creator>
	<dc:description xml:lang="en">Cervical cancer is one of the most common cancer suffered in women. Chemotherapy usage often causes physical and psychological side effects in patients. This study aims to determine the antioxidant and cytotoxic effects of the ethyl acetate fraction of melinjo seeds (Gnetum gnemon L.) on HeLa cervical cancer cells through in vitro and in silico assays. Melinjo seed was extracted by maceration using ethanol 70% and fractionated with ethyl acetate to obtain the Ethyl Acetate Fraction of Melinjo Seed (EAFMS). The identification of the active compounds group was done using Thin Layer Chromatography (TLC) method. In vitro studies were conducted on antioxidant tests using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method and cytotoxic activity test using 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) Assay. In silico test for molecular docking analyzed by Autodock Vina method. The TLC analysis of EAFMS showed the presence of the stilbenoid compounds group. The antioxidant activity of EAFMS is weak, with an IC50 value of 175.8 g/ml. Cytotoxic activity of EAFMS is categorized as toxic to HeLa cancer cells with an IC50 value of 21.69 g/ml, while EAFMS has a synergistic effect combined with doxorubicin as a standard drug with a combination index (CI) value of 0.24-0.80. A molecular docking test of gnetin C with VHR receptor found a strong and stable bond with a docking score of -8.3 kcal/mol. Thus, EAFMS has the potential to be used as a chemopreventive agent for cervical cancer and can be combined with doxorubicin.</dc:description>
	<dc:publisher xml:lang="en">Bogor Agricultural University, Indonesia</dc:publisher>
	<dc:date>2023-06-19</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://journal.ipb.ac.id/hayati/article/view/45500</dc:identifier>
	<dc:identifier>10.4308/hjb.30.5.864-873</dc:identifier>
	<dc:source xml:lang="en">HAYATI Journal of Biosciences; Vol. 30 No. 5 (2023): September 2023; 864-873</dc:source>
	<dc:source>2086-4094</dc:source>
	<dc:source>1978-3019</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://journal.ipb.ac.id/hayati/article/view/45500/25722</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2023 Rawi Ingra Savitri, Nuha Haifa Arifin, Rifki Febriansah</dc:rights>
</oai_dc:dc>